Sativex - Investigational Cannabis-Based Treatment for Pain and Multiple Sclerosis
Key Data:
Drug (Brand / Generic)
Sativex
Company / Licensee
GW Phamaceuticals/Bayer/Otsuka
Therapy Class
Cannabis extract containing THC and CBD
Product Description
Whole plant medicinal cannabis extract
Current Indication
Pain and symptom relief in MS and neuropathic-related cancer pain
Market Sector
CNS – pain
Development Status
Approved Canada; pre-registration in the UK; Phase II/III US to be complete by the end of 2009
